Syneos Health to Present at Upcoming Investors Conferences

May 21, 2018

RALEIGH, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at three upcoming investor conferences:

  • Jefferies Global Healthcare Conference in New York, N.Y., on Tuesday, June 5, 2018, at 10:00 a.m. ET 
  • William Blair Annual Growth Stock Conference in Chicago, Ill., on Tuesday, June 12, 2018, at 8:50 a.m. CT 
  • Goldman Sachs Annual Global Healthcare Conference in Rancho Palos Verdes, Calif., on Wednesday, June 13, 2018, at 8:40 a.m. PT 

A live webcast of the events will be available on the Company’s Investor Relations website at Additionally, presentation materials and archived audio of the presentations will be available for 180 days on the site.

About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit


Investor Relations:
Ronnie Speight
Vice President, Investor Relations
+1 919 745 2745

Danielle DeForge
Senior Director, External Communications
+1 202 210 5992

Primary Logo

Source: Syneos Health